Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Camurati-Engelmann disease

Other Names for this Disease
  • CED
  • Diaphyseal dysplasia 1, progressive
  • DPD1
  • Engelmann disease
  • PDD
More Names
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might Camurati-Engelmann disease be treated?

Clinical management of Camurati-Engelmann disease relies on long-term treatment by corticosteroids which contribute to improvement of clinical and radiological signs.[1][2][3]
Last updated: 8/1/2013

  1. Camurati engelmann disease. Orphanet. February 2005; Accessed 4/17/2008.
  2. Katrien Janssens, Wendy Ballemans, Wim Van Hul. Camurati-Engelmann Disease. NORD Guide to Rare Disorders. 2003; Accessed 4/17/2008.
  3. Stephanie E Wallace, William R Wilcox. Camurati-Engelmann Disease. GeneReviews. August 16, 2006; Accessed 4/17/2008.

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Camurati-Engelmann disease. Click on the link to go to to read descriptions of these studies.
  • The U.S. National Institutes of Health, through the National Library of Medicine, developed to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled Evaluation and Treatment of Skeletal Diseases which may be of interest to you.
  • Orphanet lists clinical trials, research studies, and patient registries enrolling people with this condition. Click on Orphanet to view the list.